Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Duodenal Neoplasms × Rivaroxaban × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Pancreatic Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Duodenal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

apixaban 1 Rivaroxaban 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03139487 2020-01-06

PRIORITY

Asan Medical Center

Phase 2 Unknown

GastrointestinalSarcoma

Biliary Tract Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡